Author:
Finke James H.,Goel Mahesh
Reference131 articles.
1. Oliver RT, Miller RM, Mehta A, Barnett MJ. A phase 2 study of surveillance in patients with metastatic renal cell carcinoma and assessment of response of such patients to therapy on progression. Mol Biother 1988;1(1):14–20.
2. Edwards MJ, Anderson JA, Angel JR, Harty JI. Spontaneous regression of primary and metastatic renal cell carcinoma. J Urol 1996;155(4):1385.
3. Kliem V, Kolditz M, Behrend M, et al. Risk of renal cell carcinoma after kidney transplantation. Clin Transplant 1997;11(4):255–258.
4. Kunisch-Hoppe M, Hoppe M, Bohle RM, et al. Metastatic RCC arising in a transplant kidney. Eur Radiol 1998;8(8):1441–1443.
5. Finke JH, Rayman P, Hart L, et al. Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J Immunother Emphasis Tumor Immunol 1994;15(2):91–104.